Women’s Health and CRISPR: Novel Cervical Cancer, Endometrial Cancer,Condyloma, Endometriosis, Fibroids and PCOS Diagnostic andTreatment Tools with CRISPR Nucleic Acid Approaches

John Yeh
In: Current Womens Health Reviews · 2022 · vol. 18(3) · doi:10.2174/157340481803220425132932 · W4224987346
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-07-29 ⓘ

This review explores novel CRISPR-based diagnostic and treatment tools for various women's health conditions, including cervical cancer, endometriosis, fibroids, and PCOS.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-28 · read from full text ⓘ

This review article explores the potential of CRISPR-Cas nucleic acid approaches for diagnosing and treating various women’s health conditions, including cervical cancer, endometrial cancer, condyloma, uterine fibroids, and polycystic ovary syndrome. It synthesizes existing literature on how genome editing tools can target specific genetic mechanisms underlying these gynecological disorders, such as oncogenic HPV genes in cervical cancer and chromatin landscape alterations in leiomyomas. The paper highlights emerging therapeutic strategies and diagnostic applications derived from recent advancements in CRISPR technology while acknowledging the current stage of clinical translation. Relevance to endometriosis: listed as one indication for CRISPR-based treatment tools, though the paper's main focus is a broad overview of multiple gynecological conditions rather than deep mechanistic analysis of endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 3,961 characters · extracted from oa-doi-fallback · click to expand
[1] Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014 Nov 28; 346(6213): 1258096. [http://dx.doi.org/10.1126/science.1258096] [PMID: 25430774] [http://dx.doi.org/10.1126/science.1258096] [PMID: 25430774] [2] Doudna JA. The promise and challenge of therapeutic genome editing. Nature. 2020 Feb; 578(7794): 229-236. Epub 2020 Feb 12. [http://dx.doi.org/10.1038/s41586-020-1978-5] [PMID: 32051598] [http://dx.doi.org/10.1038/s41586-020-1978-5] [PMID: 32051598] [3] Uyhazi KE, Bennett J. A CRISPR view of the 2020 Nobel Prize in Chemistry. J Clin Invest 2021; 131(1): e145214. [http://dx.doi.org/10.1172/JCI145214] [http://dx.doi.org/10.1172/JCI145214] [4] Abudayyeh O, Gootenberg J, Essletzbichler P, et al. RNA targeting with CRISPR–Cas13. Nature 2017; 550: 280-4. [http://dx.doi.org/10.1038/nature24049] [http://dx.doi.org/10.1038/nature24049] [5] Zhang W, Liu Y, Zhou X, Zhao R, Wang H. Applications of CRISPR-Cas9 in gynecological cancer research. Clin Genet 2020; 97: 827-34. [http://dx.doi.org/10.1111/cge.13717] [http://dx.doi.org/10.1111/cge.13717] [6] Zhen S, Li X. Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer. Cell Physiol Biochem 2017; 44: 2455-66. [http://dx.doi.org/10.1159/000486168] [http://dx.doi.org/10.1159/000486168] [7] Kavlashvili T, Jia Y, Dai D, Meng X, Thiel KW, Leslie KK, et al. (2016) Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer. PLoS ONE 11(2): e0148912. [http://dx.doi.org/10.1371/journal.pone.0148912] [http://dx.doi.org/10.1371/journal.pone.0148912] [8] Liu YC, Cai ZM, Zhang XJ. Reprogrammed CRISPR-Cas9 targeting the conserved regions of HPV6/11 E7 genes inhibits proliferation and induces apoptosis in E7-transformed keratinocytes. Asian J Androl 2016; 18: 475-9. [http://dx.doi.org/10.4103/1008-682X.157399] [http://dx.doi.org/10.4103/1008-682X.157399] [9] Baker C, Hayden MS. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease [version 1; peer review: 2 approved] F1000Research 2020, 9:281 [http://dx.doi.org/10.12688/f1000research.23185.1] [http://dx.doi.org/10.12688/f1000research.23185.1] [10] Sahin C, Mamillapalli R, Yi KW, Taylor HS. microRNA Let-7b: A Novel treatment for endometriosis. J Cell Mol Med 2018; 22(11): 5346-53. [http://dx.doi.org/10.1111/jcmm.13807] [http://dx.doi.org/10.1111/jcmm.13807] [11] Tapmeier TT, Rahmioglu N, Lin J, et al. Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis. Sci Transl Med 2021; 13: eabd6469. [http://dx.doi.org/10.1126/scitranslmed.abd6469] [http://dx.doi.org/10.1126/scitranslmed.abd6469] [12] Moyo MB, Parker JB, Chakravarti D. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas. Nature communications 2020; 11(1) [1019]. [http://dx.doi.org/10.1038/s41467-020-14701-6] [http://dx.doi.org/10.1038/s41467-020-14701-6] [13] Machado-Lopez A, Simón C, Mas A. Molecular and Cellular Insights into the Development of Uterine Fibroids. Int. J. Mol. Sci. 2021, 22, 8483. [http://dx.doi.org/10.3390/ijms22168483] [http://dx.doi.org/10.3390/ijms22168483] [14] Zhou J, Jin X, Sheng Z, Zhang Z. miR-206 serves an important role in polycystic ovary syndrome through modulating ovarian granulosa cell proliferation and apoptosis. Exp Ther Med. 2021 Mar; 21(3): 179. Epub 2021 Jan 5. [http://dx.doi.org/10.3892/etm.2021.9610] [PMID: 33500693] [PMCID: PMC7818533] [http://dx.doi.org/10.3892/etm.2021.9610] [PMID: 33500693] [PMCID: PMC7818533] [15] Chen Z, Yu HJ, Shi X, Warren CR, Lotta LA, Friesen M, Meissner TB, Langenberg C, Wabitsch M, Wareham N, et al. Functional screening of candidate causal genes for insulin resistance in human preadipocytes and adipocytes. Circ Res. 2020; 126:330–346. [http://dx.doi.org/10.1161CIRCRESAHA.119.315246] [http://dx.doi.org/10.1161CIRCRESAHA.119.315246] 20 1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (14)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK